Africa has seen the largest growth in genito urinary system and sex hormones-related trials over the past decade
We've analysed 10 years' worth of clinical trials data from GlobalData to pick out key...
Analysis
Digitising the pharma supply chain
The Covid-19 pandemic has highlighted the need for security and traceability at every step of...
BYJU’s, India’s most valuable unicorn, is giving the UK an education in AI technology
Byju’s expansion comes to the UK with an innovation hub exploring AI technology in education.
Astellas, Bayer and Mithra likely to turn up the heat in hot flashes market
Late-stage approaches to treat menopause-related hot flashes are expected to hit the market and may...
Magazine: The dark side of supply shortages
In this issue: Tackling the rise in illegal online pharmacies caused by drug shortages, how...
The dark consequences of drug supply shortages
Drug shortages caused by supply chain issues or political decisions can open the door to illicit online pharmacies.
Filings buzz in pharmaceuticals: 25% increase in robotics mentions since Q2 2020
The frequency of sentences related to robotics between July 2020 and June 2021 was 50% higher than in 2016.
Aducanumab: will Biogen’s Aduhelm recover from its rocky start?
The US approval of Alzheimer’s drug aducanumab was met with controversy and the resignation of several FDA panel members.
Digital media hiring levels in the pharmaceutical industry dropped in October 2021
40% of the companies included in our analysis recruited for at least one digital media position.
Paxlovid: what we know about Pfizer’s Covid-19 pill
Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid.
Pfizer and Takeda deals put spotlight back on value-based pricing programs
Efforts to pay for a drug based on its value were limited by logistics, but recent deals for cancer drugs could be a step forward
